These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12570684)

  • 1. Drug discovery today.
    Schwardt O; Kolb H; Ernst B
    Curr Top Med Chem; 2003; 3(1):1-9. PubMed ID: 12570684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
    Roberts SA
    Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive assessment of ADMET risks in drug discovery.
    Wang J
    Curr Pharm Des; 2009; 15(19):2195-219. PubMed ID: 19601823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead generation--enhancing the success of drug discovery by investing in the hit to lead process.
    Alanine A; Nettekoven M; Roberts E; Thomas AW
    Comb Chem High Throughput Screen; 2003 Feb; 6(1):51-66. PubMed ID: 12570752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of small molecule libraries for NMR screening and other applications in drug discovery.
    Jacoby E; Davies J; Blommers MJ
    Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubility and permeability measurement and applications in drug discovery.
    Burton PS; Goodwin JT
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):101-11. PubMed ID: 20053165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ID NMR Methods in ligand-receptor interactions.
    Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ
    Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AutoClickChem: click chemistry in silico.
    Durrant JD; McCammon JA
    PLoS Comput Biol; 2012; 8(3):e1002397. PubMed ID: 22438795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization.
    Bruno A; Costantino G; Sartori L; Radi M
    Curr Med Chem; 2019; 26(21):3838-3873. PubMed ID: 29110597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The devil is still in the details--driving early drug discovery forward with biophysical experimental methods.
    Lundqvist T
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):513-9. PubMed ID: 16022188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening: are we there yet?
    Jalaie M; Shanmugasundaram V
    Mini Rev Med Chem; 2006 Oct; 6(10):1159-67. PubMed ID: 17073716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on bioanalytical mass spectrometry and automation in drug discovery.
    Janiszewski JS; Liston TE; Cole MJ
    Curr Drug Metab; 2008 Nov; 9(9):986-94. PubMed ID: 18991596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysics in drug discovery: impact, challenges and opportunities.
    Renaud JP; Chung CW; Danielson UH; Egner U; Hennig M; Hubbard RE; Nar H
    Nat Rev Drug Discov; 2016 Oct; 15(10):679-98. PubMed ID: 27516170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of NMR screening in drug discovery.
    Fejzo J; Lepre C; Xie X
    Curr Top Med Chem; 2003; 3(1):81-97. PubMed ID: 12570779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From in vivo to in vitro/in silico ADME: progress and challenges.
    Van de Waterbeemd H
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):1-4. PubMed ID: 16922647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Development of Novel Drugs.
    Erakovic Haber V; Spaventi R
    Prog Mol Subcell Biol; 2017; 55():91-104. PubMed ID: 28238036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Screening of Compound Libraries Using a Consensus of Orthogonal Methodologies.
    Myrianthopoulos V; Lambrinidis G; Mikros E
    Methods Mol Biol; 2018; 1824():261-277. PubMed ID: 30039412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying small-molecule lead compounds: the screening approach to drug discovery.
    Bevan P; Ryder H; Shaw I
    Trends Biotechnol; 1995 Mar; 13(3):115-21. PubMed ID: 7766218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.